Table 1. Description of the analyzed microarray data sets.
| Experiments | Samples | Reference |
|---|---|---|
|
GSE8596 |
Ewing tumors (7 cell lines) |
42 |
|
GSE12102 |
Ewing tumors (37 tumors) |
43 |
|
GSE17679 |
Ewing tumors (11 cell lines) |
44 |
|
GSE34620 |
Ewing tumors (117 tumors) |
45 |
|
GSE34800 |
Ewing tumors (4 tumors) |
46 |
|
GSE36133 |
Ewing tumors (9 cell lines) |
47 |
|
GSE3526 |
Normal tissues (160 selected samples) |
48 |
|
GSE3526 |
HUVECS (2 samples) |
48 |
|
GSE9677 |
HUVECS (3 un-stimulated samples) |
49 |
|
GSE6257 |
Lymphatic endothelial cells (3 samples) |
50 |
|
GSE8590 |
Embryonic stem cells (6 samples) |
51 |
|
GSE22392 |
Embryonic stem cells (2 samples) |
52 |
|
GSE26862 |
Embryonic stem cells (3 samples) |
53 |
|
GSE3526 |
Testis (5 samples) |
48 |
|
GSE6969 |
Sperm (13 normal samples) |
54 |
|
GSE8665 |
MSC (14 samples; transgenic) |
42 |
|
GSE9520 |
MSC (6 samples) |
55 |
| GSE31215 | MSC (8 samples; transgenic) | 19 |
DNA microarray data sets from the sources above were down-loaded from the GEO database and used for analysis of known CTA and identification of putative new CTA in EFT.